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ABSTRACT:  
Background – Although previous studies demonstrated an association between depressive 
symptoms and cardiac mortality after acute myocardial infarction (AMI) little is know about the 
possible mechanisms of this association. The aim of this study was to determine whether 
depressed patients present a cardiac autonomic dysfunction and whether this could represent the 
mediator of the influence of depression on their prognosis. 
Methods – One hundred consecutive patients with AMI were recruited between January and 
December 1998. Major Depressive Disorder (MDD) was diagnosed by structured clinical 
interview and the presence of symptoms of depression was evaluated with self-administered Beck 
Depression Inventory (BDI). The influence of depression on autonomic nervous system was 
investigated measuring heart rate variability (HRV) and heart rate (HR) during 24-hour 
electrocardiographic monitoring. The endpoints of the study were all-cause mortality, recurrent-
AMI, revascularization and a composite end-point of all the previous. Potential cofounders for 
depression status and events were entered into a multivariate regression model.  
Results – Fifteen patients met the criteria for MDD and 35 patients showed mild-to-moderate 
symptoms of depression; women had a higher prevalence of depression than men (35% vs 9%; 
p<0.01). Depression was not related to the severity of ischaemic disease or to other clinical and 
demographic variables. Patients with MDD showed lower HRV (76±25SD vs 99±33SD msec; 
p<0.01) and higher HR (77±12SD vs 68±9SD bpm; p<0.01) than patients without MDD; 
moreover mild to moderate symptoms of depression (BDI score³10) were associated with lower 
HRV (84±25SD vs 102±35SD msec; p=0.01) but not with significantly higher HR.  
After a mean follow-up of 60 months MDD was associated with an increase of all-cause mortality 
(OR 12; 95% CI 2.6-56; p<0.01) and of composite end-point (OR 2; 95% CI 1.2-3.6; p=0.01) but 
not with re-AMI and revascularization. In a simple regression HRV values were predictor of 
mortality (p<0.01). However when added in the multiple regression model HRV did not have an 
independent correlation with the endpoints considered and did not modified the correlation 
between depression and mortality.    
Conclusions – Patients with post-AMI depression have a cardiac autonomic dysfunction as 
reflected by decreased HRV and increased HR. This autonomic dysfunction seems not to be an 
independent mediator of the increased mortality observed in depressed patients during 5-year 
follow-up.  
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INTRODUCTION 
Depression after acute myocardial infarction (AMI) is associated with higher patient morbidity 
and mortality [1-5]. Little is known about the possible pathophysiologic mechanism of this 
association but factors such as lack of compliance on risk reducing recommendations and 
prescribed therapies [6] and high dropout from rehabilitation programs are common in depressed 
patients [7]. In addition to this alterations of behaviour, depression may be responsible of 
biological effects such as increased platelet activation [8] and cardiac autonomic dysfunction 
involving arrhythmias and cardiac deaths [9-11]. Heart rate variability (HRV) and mean heart rate 
(HR) are methods widely used to evaluate cardiac autonomic function and have been reported as 
relevant predictors of post-AMI mortality. 
The aim of this study was to determine whether post-AMI depression is associated with decreased 
HRV and/or increased HR and whether these foundings represent the mediators of depression on 
patients prognosis.   
 
METHODS             
One hundred consecutive patients admitted in our coronary care unit for AMI were enrolled 
between January and December 1999. The protocol of the study was approved by the institutional 
review board and participants provided informed written consent. The diagnosis of AMI was 
based on the Joint ESC/ACC definition [12]. In-hospital mortality, the presence of other severe 
psychiatric diseases, alcoholism or antidepressant therapy were considered as exclusion criteria. 
All patients underwent examinations and therapies considered the most appropriate by the 
attending cardiologist.  
The presence of Major Depression Disorder (MDD) was evaluated with council interview 
structured on the basis of the Diagnostic and Statistical Manual of Mental Disorders fourth edition 
(DSM IV) [13] by two psychiatrists between the 7th and the 14th day from admission. Diagnosis of 
MDD was defined as depressed humour or lost of interest together with at least other four of the 
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following symptoms: changes in the weight or in the hunger, lost or excessive sleep, tiring or lost 
of energies, slowness or restlessness, difficulty to concentrate or fall asleep, guilty feelings, 
decrease in self-esteem, thoughts of death or suicide. The listed disturbs had to be present since 
the hospitalisation and causing a functional damage representing a change towards the past.  
Patients were also asked to answer the self-administered Beck Depression Inventory (BDI) to 
measure the severity of humour disease investigated by 21 items on behaviours and symptoms 
commonly observed in depressed patients [14]. Patients with BDI ³10 were considered affected 
by mild-to-moderate symptoms of depression. 
Heart rate variability was measured with a 24-hour Holter monitoring after patient mobilisation 
performed with a DELMar Digicoder. It was obtain before rather than after discharge in order to 
minimised the potential confound between depression and physical activity. Standard deviation of 
R-waves intervals of consecutive QRS complexes (Standard Deviation Normal to Normal 
=SDNN) was used to measure HRV. It reflects all the time-domain HR variability and it is an 
independent predictor of mortality after AMI [15]. 
All patients underwent echocardiography and 67 patients coronary angiography. 
The interviewing cardiologist was blind to the results of the psychiatric evaluations. 
Follow-up: a first medical examination was performed after 3-6 month and a phone interview or 
an ambulatory examination every year. The follow-up was ended after 5 years. For fatal events 
the death certificates diagnosis was used. 
Endpoints: the adverse events we considered were: all-cause mortality, recurrent AMI, need to 
further revascularization after discharge (percutaneous or surgical), and a composite end-point of 
all the previous.  
Statistical analysis: continuous variables including age, creatinephosfokinase (CPK), 
Creatinephosfokinase Muscolar-Brain (CPK-MB) are expressed as medians ± standard deviation 
and categorical parameters as percentages of the respective strata. The Student t test was used to 
compare homogeneous continuous variables and the Mann-Whitney unpaired U rank sum test for 
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non homogeneous distribution (CPK, CPK-MB). The Maximum-Likelihood Chi square test was 
performed for the categorical variables. All the tests were two-tailed. The multiple regression 
analyses were run as best subset models applying odds ratio (OR) likelihood scores using as 
potential confounders in the model the age and gender. 
For the composite end-point a multiple regression model was also performed considering as 
potential confounders all the following variables: age, gender, diabetes mellitus, dyslipidaemia, 
previous AMI, anterior AMI, non preserved left ventricle ejection fraction, acute treatment with 
thrombolysis or primary coronary angioplasty and HRV value. 
The Kaplan Meier survival and event free actuarial method was used to compare events incidence 
by different subgroups of patients. The Cox’s test was used to test statistical significance of the 
observed differences. 
 
RESULTS 
One hundred patients were enrolled, 77 males and 23 females, with a mean age of 62 ±13SD 
years. According to the DSM IV criteria 15 patients were affected by MDD; the incidence of 
MDD was higher among women than in men (35% vs 9%; p<0.01). According to BDI 35 patients 
showed mild-to-moderate symptoms of depression (BDI ³10), 30% of men vs 52% of women 
(p=0.09). The mean BDI value of the entire study population was 8.5 ±8.4SD; patients with MDD 
showed higher mean values of BDI compared to their counterparts without MDD (22 ±10SD vs 6 
±5SD, p<0.01).  
No statistical difference was found for all the variables taken in account, except for gender, when 
comparing demographic and clinical characteristics of patients with and without depression 
(Table 1).  
Ecg-Holter evaluation: patients with MDD showed significantly lower HRV (SDNN 76 ±25SD 
vs 99 ±33SD msec; p=0.01) and higher HR (77 ±12SD vs 68 ±9SD bpm; p<0.01) compared to 
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patients without MDD. HRV was significantly decreased also in patients with BDI ³10 (84 
±25SD vs 102 ±35SD msec; p=0.01) and the HR was higher (71 ±11SD vs 67 ±9SD bpm) but 
without statistical significance (p=0.07). 
Follow-up: 98 of 100 patients ended the study with a mean follow-up of 60 months (range 54-69). 
Thirty major adverse events occurred and 6 patients died during the follow-up. In the multiple 
regression analysis MDD emerged as a significant  risk factors for mortality [odds ratio (OR) 12; 
95% confidence interval (CI) 2.6 to 56; p<0.01)] and for composite end-point both when 
correcting for age and gender (OR 1.9; 95% CI 1.01 to 3.4; p=0.04) than when inserting in the 
model other clinical possible covariates (diabetes mellitus, dyslipidaemia, previous AMI, anterior 
AMI, non preserved left ventricle ejection fraction, acute treatment with thrombolysis or primary 
coronary angioplasty and HRV value)(OR 2; 95% CI 1.2 to3.6; p=0.01). Similar to MDD also 
BDI ³10 was significantly related in multivariate analysis corrected for age and gender to long-
term mortality (OR 9; 95% CI 2 to 43; p<0.01) and to the composite end-point (OR 1.03;  95% CI 
1 to 1.1; p=0.02). Both MDD and BDI did not have an independent effect on the revascularization 
and re-infarction rates (Table 2).  
A significant inverse correlation in simple regression was observed between values of HRV and 
the adverse events occurred (p<0.01). When added in the multiple regression model HRV did not 
have an independent correlation (p=0.39) with the endpoints considered and did not modified the 
correlation between depression and mortality (p=0.01), suggesting that HRV was not the mediator 
of the influence of depression on patients prognosis. 
The Kaplan Meier event-free curves for all-cause mortality showed a significant trend between 
patients with and without MDD (event-free: 79% vs 96%; p=0.008) (Figure1a). Furthermore for 
the composite end-point a significant difference in event-free survival was observed (50% vs 
73%;  p=0.02) starting to diverge from the 12th month of follow-up (Figure 1b). For the others 
tested end-points non statistical significance emerged in event-free curves. 
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 DISCUSSION  
Depression is a common co morbidity in patients with AMI, similarly to previous researches in 
our sample 35% of patients showed mild-to-moderate symptoms of depression (BDI ³10) and 
15% were affected by MDD[1-4,19]. The higher incidence of depression observed in women is 
well known in general population, although in patients with AMI this finding was not uniformly 
referred from previous studies [1-4,19].  
Several authors observed that depressive symptoms increase mortality risk after AMI, raising the 
question if depression is a causative factor contributing to a worse prognosis, a consequence, or 
both [1-5]. In the present study, apart from gender, the presence of depression was not correlated 
with any other clinical and demographic variables or with severity of ischaemic disease, 
suggesting that depression was not a consequence of a worse disease.  
We observed that both MDD and mild-to-moderate symptoms of depression were associated with 
increased mortality, even more patients with MDD showed higher risk of mortality than patients 
with mild-to-moderate symptoms suggesting a direct correlation between severity of depression 
and influence on the prognosis.  
This finding were not univocally referred in literature. Frasure-Smith et al. considering 225 
patients with AMI, founded that MDD and BDI ³10 were both significantly associated with 
patients cardiac mortality at 6 months follow-up. Although among those patients that survived 
more than 6 months MDD no longer had an impact on mortality, while BDI ³10 showed an 
impact even stroger [4]. Similarly Bush et al. observed that even minimal symptoms of depression 
(BDI 4 to 9) increased mortality risk after AMI, while the presence of a major psychiatric 
disorders (MDD, dysthymia, bipolar psychiatric disorder) had no influence on patients prognosis 
[1]. This finding are not completely clear since patients with MDD should have a higher BDI 
score and of consequence a stronger association with mortality, fact surprisingly not proven in the 
previously listed researches.  
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The association between post-AMI depression and mortality has been indirectly put in question by 
the ENRICHD clinical trial. This study compared psychological and pharmacological anti-
depressive therapy to usual care in 2481 post-AMI depressed patients. After an average follow-up 
of 29 months anti-depressive therapy failed to reduce the risk of mortality [17] suggesting that the 
worse prognosis observed in depressed  was not a consequence of the presence of depression.  
In the present study we observed that event-free curves for the composite end-point start to 
diverge after 12 months, the reason is probably not unique but the more frequent follow-up visits 
and the closer time from the event probably represents a stimulus on the unstable treatment 
compliance of the MDD patients that decreases with the passing of the months. 
The correlation of depression with other endpoints than mortality has been previously tested in 
literature. Similarly to other authors [5-20,21] we observed that depression was associated with 
increased mortality but not with revascularization and re-AMI; this observation could support the 
hypothesis of the presence of an autonomic unbalance causing arrhythmia and sudden death rather 
than other pathophysiologic mechanisms such as platelet activation. However a recent meta-
analyses of 22 studies (6367 patients) with an average follow-up of 13.7 months observed that 
depression was associated with higher risk for mortality and also for new cardiovascular events 
[18]. 
The present study shows that MDD and BDI ³10 are both associated with a relevant cardiac 
autonomic dysfunction as reflected by increased HR and decreased HRV. Those are two well 
known indices of cardiac autonomic activity and of risk stratification after AMI. Copie et al. [15] 
observed that HRV and 24-hour mean HR were strong predictors of mortality in patients with 
AMI and found that their values could compete with left ventricular ejection fraction for positive 
predictive accuracy, sensitivity and specificity. Moreover the Cardiac Arrhythmia Suppression 
Trial (CAST) reported that HRV is a predictor of post-AMI mortality largely independent from 
clinical and demographic factors [16]. The results of the present study are generally consistent 
with those of Carney et al revealing the presence of a great autonomic dysfunction in depressed 
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patients, however Carney did not evaluate the influence of this association on the prognosis with a 
clinical follow-up [11]. In the present study, during 5-year follow-up we could observed a 
significant inverse correlation between values of HRV and the composite end-point (p<0.01), 
confirming the prognostic value of HRV also in this sample. Although when inserted in the 
multiple regression model the HRV value did not have an independent correlation with any of the 
endpoints considered. Even more the correlation between depression and mortality remained 
statistically significant also inserting HRV as covariate in the multiple regression suggesting that 
this was not the mediator of the influence of depression on patients prognosis. 
 
Limits: the main limit of this study is represented by the small number of the sample and by the 
low number of deaths (six) that limits the statistical power. Furthermore even if sudden death and 
not all-causes death is the end-point most related with cardiac autonomic dysfunction and 
arrhythmias, unfortunately, routine death certificates did not allow a scientifically valid decision 
about whether deaths were to be considered as sudden or not.  
  
Conclusion – Patients with MDD and mild-to-moderate depressive symptoms after AMI had  
higher mortality and relevant dysfunction of cardiac autonomic tone, however there is no 
evidence that this unpaired autonomic function represents the mediator of this increased mortality 
observed during a long term follow-up. 
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Table 1: Clinical characteristics of patients with and without Major Depressive Disorder (MDD), 
and of patients with symptoms (BDI<10) and without symptoms (BDI ³10) of depression. (Data 
shown as number and percentage of the respective strata when not stated) 
 
 All patients Without 
MDD 
With 
MDD 
p BDI<10 BDI³10 p 
Number of patients 100 85 15  65  35   
Male 77 70 (91%) 7 (9%)  54 (70%) 23 (30%)  
Female 23 15 (65%) 8 (35%) <0.01 11 (48%) 12 (52%) 0.09 
Age (mean and SD 
in years) 
62 ± 13 62 ± 12 63 ± 10 0.71 61 ± 13 63 ± 11 0.42 
Diabetes Mellitus 14 11(13%) 3 (20%) 0.42 9 (14%) 5 (14%) 0.98 
Smoke 58  51(60%)  7 (47%) 0.58 37 (57%) 21 (60%) 0.97 
Hypertension 51  41(48%) 10 (67%) 0.57 35 (54%) 16 (46%) 0.71 
CHD family history 31  27 (32%) 4 (27%) 0.81 20 (31%) 11 (31%) 0.96 
Dislipidemia 50  43 (51%) 7 (47%) 0.98 33 (51%) 17 (49%) 0.98 
CPK (mean and SD 
in ng/ml) 
1984±1913 1947±1897 2198±2130 0.72 2034±1945 1885±1875 0.73 
CPK-MB (mean and 
SD in ng/ml) 
 
189 
 
178±142 
 
249±278 
 
0.41 
 
183±142 
 
200±218 
 
0.81 
EF<40% 16  14 (15%) 2 (18%) 0.67 8 (12%) 8 (23%) 0.21 
      ß-blockers 75    66 (78%)  9 (60%) 0.22 53 (82%) 22 (63%) 0.83 
No coronary disease 2 2 (3%) 0 / 1 (5%) 1 (2%) 0.92 
Single vessel disease 24  20 (35%) 4 (40%) 0.61 10 (47%) 14 (30%) 0.77 
Two vessels 17 14 (24%) 3 (30%) 0.73 3 (14%) 14 (30%) 0.21 
Three vassels or TC 
disease 
25  22 (38%) 3 (30%) 0.67 7 (34%) 18 (38%) 0.97 
 
 
(MDD: Major Depressive Disorder. BDI: Beck Depression Inventory score. CHD: Coronary 
Heart Disease. CPK: Creatinphosfokinase. CPK-MB Creatinphosfokinase Muscolar-Brain. 
EF: Ejection Fraction. TC: Truncus Communis) 
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Table 2: Adverse events occurred during 5-year follow-up in patients with and without Major 
Depressive Disorder (MDD), and in patients with (BDI<10) and without (BDI ³10) symptoms 
of depression. (data presented as odds ratio with confidence interval 95%, OR>1 if the event 
is more common in MDD or BDI³10 patients) 
 
 
  
Without MDD 
(84) 
 
With 
MDD 
(14) 
 
Odds Ratio 
(95% CI) 
 
 
p 
 
BDI<10 
(65) 
 
BDI³10 
(33) 
 
Odd Ratio 
(95% CI) 
 
  p 
 
Revascula
rization 
 
16 (19%) 
 
3 (21%) 
 
1 (0.4-2.2) 
 
0.96 
 
 
 
12 (19%) 
 
7 (21%) 
 
1 (0.9-1.2) 
 
0.61 
 
Recurrent 
AMI 
 
4 (5%) 
 
1 (7%) 
 
1.2 (0.7-8.3) 
 
0.12 
 
1 (2%) 
 
4 (12%) 
 
1.1 (0.9-1.1) 
 
0.09 
 
 
Mortality 
 
3 (4%) 
 
3 (21%) 
 
12 (2.6-56)  
 
<0.01 
 
3 (5%) 
 
3 (9%) 
 
9.2 (2 - 43) 
 
<0.01 
 
Total 
adverse 
events 
 
23 (27%) 
 
7 (50%) 
 
1.9 (1.1- 3.4) 
 
0.01 
 
16 (25%) 
 
14 (42%) 
 
1.1 (1-1.1) 
 
 
0.01 
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Figure 1: Event free curves (Kaplan Meier) for all-cause mortality (1a) and composite end-point (1b, all-cause 
mortality, recurrent infarction, revascularization) in the group of patients with MDD (dashed line) vs without MDD 
(continuos line). 
 
a) 
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